» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Study aim: Evaluation of the independent and combined effects of combined training with the approach of ultimate preparation and coffee consumption on blood characteristics of middle-aged men with non-alcoholic fatty liver Design: The clinical trial has three experimental groups and the control group is divided into four groups of 11 randomly, without blinding. Settings and conduct: The method of the present study is quasi-experimental and is performed with a pre-test-post-test design in three experimental groups (combined exercise group, combined exercise-coffee consumption, coffee consumption) and control group. The statistical population is middle-aged men 30-60 with non-alcoholic fatty liver with ultrasound grades 1, 2 and 3, and enzymes (ALT) and (AST) and lipid profile above normal, in Borkhar city of Isfahan. The training protocol is done 3 times a week for 60 minutes. Each session consists of 3 5-part practice sections. Consumption of coffee on a daily basis between 9 am and 11 am and in the afternoon between 3 pm and 5 pm One cup (180 cc) of Robusta coffee is consumed in the form of Turkish coffee. Participants/Inclusion and exclusion criteria: Middle-aged men 30 to 60 Year and conditions of entry: Grade 1, 2 and 3 liver disease, people with high blood lipid profile, people without cardiovascular disease and people without physical disabilities Conditions of non-entry: People with grade 4 fatty liver disease, People with physical disabilities, People with heart failure, People with lung disease Intervention groups: The first intervention, combined exercise, the second intervention of coffee consumption, which received three experimental groups of intervention and the control group did not receive any intervention.. Main outcome variables: Decreased liver grade, enzymes (AST) and (ALT) and blood lipid profile, index (BMI) and increased functional skills
IRCTID: IRCT20210521051357N1
  1. The effect of six weeks combined aerobic and resistance exercise training on some liver function parameters in Middle-aged men with non-alcoholic fatty liver disease.
  2. Effect of combined exercise (resistance exercise and high intensity interval training) versus control group on serum sirtuin 1 and 4 levels in men with non-alcoholic fatty liver disease: a randomized clinical trial
  3. Investigating the effect of empagliflozin on thyroid function in patients with non-alcoholic fatty liver disease (NAFLD)
  4. Survey the Effect of celery seed on serum levels of hepatic enzymes, lipid profile, glycemic parameters and hepatic steatosis degree in nonalcoholic fatty liver disease patients, with overweight and obesity
  5. Investigating the simultaneous effect of high global diet quality score and standard diet with and without artichoke supplementation on fasting blood sugar, lipid profile and liver function indices in patients with non-alcoholic fatty liver disease: a randomized clinical trial
  6. The effect of 12 weeks of combined exercise training on serum levels of nesfatin-1 in improving liver damage markers in men with non-alcoholic fatty liver disease.
  7. The evaluation of the effect of brewed chicory leaf consumption on liver steatosis, enzymes, metabolic syndrome components, oxidative stress markers, C-reactive protein in patients with non-alcoholic fatty liver disease
  8. Effect of combined dietary weight loss and cranberry supplementation on hepatic enzymes, steatosis and inflammatory, antioxidant and apoptosis biomarkers in patients with Non-alcoholic fatty liver disease
  9. The effects of aqueous extract of Cichorium Intybus L on non-aloholic fatty liver disease
  10. The effects of intermittent fasting diet in comparison with low calorie diet on lipid profile, glycemic status and liver fibrosis in patients with non-alcoholic fatty liver
Loading...